BRCA1
- The Voice of Science website - the Israel National Science Foundation
- No comments
Researchers from Sheba and Meir Medical Center are tracking DNA and RNA from the tumor throughout treatment. In 15%–20% of patients, a signature of DNA segments was found that changed as the tumor shrank.